1. Home
  2. Directory
  3. Montana
  4. Billings
  5. Physical Medicine Rehabilitation
  6. NPI Profile
  7. Prescriptions 1104244151

JAMES JOHNSON
Prescription History 1104244151
Physical Medicine & Rehabilitation in Billings, MT


Quality Rating: 94.3 out of 100 score

NPI Status: Active since April 06, 2014

Contact Information

801 N 29TH ST
BILLINGS, MT
ZIP 59101
Phone: (406) 238-2759
Fax: (406) 238-2723

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for JAMES JOHNSON, an active Physical Medicine & Rehabilitation specialist practicing in Billings, MT. Our medical registry currently tracks 10 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 374 documented patient claims. Among these therapy options, the most frequently utilized medication is Baclofen, which accounts for 72 claims alone.

Medication Index

Baclofen

Generic Formulation: BaclofenSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 72
30-Day Fills 82.1
Days Supply 2,384
MT State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills40.7
Peer Average Days Supply1,037
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 132.3% higher than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,649.58 across this reporting matrix range.

Provider Avg Cost Per Claim

$36.80

State Avg Cost Per Claim

$29.04

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist of GABA-B RECEPTORS. It is used in the treatment of MUSCLE SPASTICITY, especially that due to SPINAL CORD INJURIES. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission.

Therapeutic Applications

Baclofen is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury/disease). It works by helping to relax the muscles.

Celecoxib

Generic Formulation: CelecoxibSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 32
30-Day Fills 39.0
Days Supply 1,155
MT State Average Benchmarks
Peer Average Claims36.0
Peer Average 30-Day Fills60.0
Peer Average Days Supply1,731
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,443.26 across this reporting matrix range.

Provider Avg Cost Per Claim

$45.10

State Avg Cost Per Claim

$45.21

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrazole derivative and selective CYCLOOXYGENASE 2 INHIBITOR that is used to treat symptoms associated with RHEUMATOID ARTHRITIS; OSTEOARTHRITIS and JUVENILE ARTHRITIS, as well as the management of ACUTE PAIN.

Therapeutic Applications

This medication is a nonsteroidal anti-inflammatory drug (NSAID), specifically a COX-2 inhibitor, which relieves pain and swelling (inflammation). It is used to treat arthritis, acute pain, and menstrual pain and discomfort. The pain and swelling relief provided by this medication helps you perform more of your normal daily activities. If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section. This drug works by blocking the enzyme in your body that makes prostaglandins. Decreasing prostaglandins helps to reduce pain and swelling.

Cyclobenzaprine Hcl

Generic Formulation: Cyclobenzaprine HclSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 37
30-Day Fills 47.0
Days Supply 1,350
MT State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills35.6
Peer Average Days Supply869
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 32.1% more claims than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $186.04 across this reporting matrix range.

Provider Avg Cost Per Claim

$5.03

State Avg Cost Per Claim

$14.21

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Cyclobenzaprine is used short-term to treat muscle spasms. It is usually used along with rest and physical therapy. It works by helping to relax the muscles. This medication is not recommended for use in older adults because they may be at greater risk for side effects while using this drug. Ask the doctor or pharmacist for details.

Diclofenac Sodium

Generic Formulation: Diclofenac SodiumSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 21
30-Day Fills 21.0
Days Supply 420
MT State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills34.9
Peer Average Days Supply764
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $536.84 across this reporting matrix range.

Provider Avg Cost Per Claim

$25.56

State Avg Cost Per Claim

$27.77

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.

Therapeutic Applications

See also Warning section. This medication is used to relieve joint pain from arthritis. Diclofenac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain.

Gabapentin

Generic Formulation: GabapentinSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 66
30-Day Fills 83.5
Days Supply 2,483
MT State Average Benchmarks
Peer Average Claims77.0
Peer Average 30-Day Fills120.3
Peer Average Days Supply3,396
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,283.52 across this reporting matrix range.

Provider Avg Cost Per Claim

$19.45

State Avg Cost Per Claim

$17.93

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Hydrocodone-Acetaminophen

Generic Formulation: Hydrocodone/AcetaminophenSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 366
MT State Average Benchmarks
Peer Average Claims61.0
Peer Average 30-Day Fills61.5
Peer Average Days Supply1,197
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 78.7% less volume than the regional standard for practitioners inside MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $235.04 across this reporting matrix range.

Provider Avg Cost Per Claim

$18.08

State Avg Cost Per Claim

$19.42

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to relieve moderate to severe pain. It contains an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen). Hydrocodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Meloxicam

Generic Formulation: MeloxicamSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 46
30-Day Fills 52.3
Days Supply 1,570
MT State Average Benchmarks
Peer Average Claims47.0
Peer Average 30-Day Fills83.9
Peer Average Days Supply2,429
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $98.70 across this reporting matrix range.

Provider Avg Cost Per Claim

$2.15

State Avg Cost Per Claim

$5.59

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzothiazine and thiazole derivative that acts as a NSAID and cyclooxygenase-2 (COX-2) inhibitor. It is used in the treatment of RHEUMATOID ARTHRITIS; OSTEOARTHRITIS; and ANKYLOSING SPONDYLITIS.

Therapeutic Applications

Meloxicam is used to help relieve moderate to severe pain. Meloxicam is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. This effect helps to decrease swelling or pain.

Methocarbamol

Generic Formulation: MethocarbamolSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 39
30-Day Fills 53.5
Days Supply 1,563
MT State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills28.6
Peer Average Days Supply623
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 62.5% higher than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,034.59 across this reporting matrix range.

Provider Avg Cost Per Claim

$26.53

State Avg Cost Per Claim

$11.34

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A centrally acting muscle relaxant whose mode of action has not been established. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1206)

Therapeutic Applications

Methocarbamol is used to treat muscle spasms/pain. It is usually used along with rest, physical therapy, and other treatment. It works by helping to relax the muscles.

Pregabalin

Generic Formulation: PregabalinSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 37
30-Day Fills 49.5
Days Supply 1,383
MT State Average Benchmarks
Peer Average Claims34.0
Peer Average 30-Day Fills43.8
Peer Average Days Supply1,230
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,134.94 across this reporting matrix range.

Provider Avg Cost Per Claim

$30.67

State Avg Cost Per Claim

$36.11

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A gamma-aminobutyric acid (GABA) derivative that functions as a CALCIUM CHANNEL BLOCKER and is used as an ANTICONVULSANT as well as an ANTI-ANXIETY AGENT. It is also used as an ANALGESIC in the treatment of NEUROPATHIC PAIN and FIBROMYALGIA.

Therapeutic Applications

This medication is used to treat pain caused by nerve damage due to diabetes, shingles (herpes zoster) infection, or spinal cord injury. This medication is also used to treat pain in people with fibromyalgia. It is also used with other medications to treat certain types of seizures (focal seizures).

Tizanidine Hcl

Generic Formulation: Tizanidine HclSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 11
30-Day Fills 23.0
Days Supply 690
MT State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills39.4
Peer Average Days Supply975
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 64.5% less volume than the regional standard for practitioners inside MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $63.02 across this reporting matrix range.

Provider Avg Cost Per Claim

$5.73

State Avg Cost Per Claim

$11.63

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury). It works by helping to relax the muscles.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like JAMES JOHNSON provides transparency into local medical care patterns within Billings, MT.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Physical Medicine & Rehabilitation** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.